Literature DB >> 9502542

Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations.

A F Lehman1, D M Steinwachs.   

Abstract

Beginning in 1992, the Agency for Health Care Policy and Research and the National Institute of Mental Health funded the Schizophrenia Patient Outcomes Research Team (PORT) to develop and disseminate recommendations for the treatment of schizophrenia based on existing scientific evidence. These Treatment Recommendations, presented here in final form for the first time, are based on exhaustive reviews of the treatment outcomes literature (previously published in Schizophrenia Bulletin, Vol. 21, No. 4, 1995) and focus on those treatments for which there is substantial evidence of efficacy. The recommendations address antipsychotic agents, adjunctive pharmacotherapies, electroconvulsive therapy, psychological interventions, family interventions, vocational rehabilitation, and assertive community treatment/intensive case management. Support for each recommendation is referenced to the previous PORT literature reviews, and the recommendations are rated according to the level of supporting evidence. The PORT Treatment Recommendations provide a basis for moving toward "evidence-based" practice for schizophrenia and identify both the strengths and limitations in our current knowledge base.

Entities:  

Mesh:

Year:  1998        PMID: 9502542     DOI: 10.1093/oxfordjournals.schbul.a033302

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  160 in total

Review 1.  Fortnightly review. Treatment of schizophrenia.

Authors:  J McGrath; W B Emmerson
Journal:  BMJ       Date:  1999-10-16

Review 2.  The global burden of mental disorders.

Authors:  T B Ustün
Journal:  Am J Public Health       Date:  1999-09       Impact factor: 9.308

3.  Identifying clinical competencies that support rehabilitation and empowerment in individuals with severe mental illness.

Authors:  A S Young; S L Forquer; A Tran; M Starzynski; J Shatkin
Journal:  J Behav Health Serv Res       Date:  2000-08       Impact factor: 1.505

4.  Adequacy of treatment for serious mental illness in the United States.

Authors:  Philip S Wang; Olga Demler; Ronald C Kessler
Journal:  Am J Public Health       Date:  2002-01       Impact factor: 9.308

5.  Determinants of anti-psychotic medication compliance in a multicultural population.

Authors:  S J Ziguras; S Klimidis; T J Lambert; A C Jackson
Journal:  Community Ment Health J       Date:  2001-06

Review 6.  Psychosocial treatments for schizophrenia.

Authors:  A S Bellack; S A Brown
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

7.  The incarceration of individuals with severe mental disorders.

Authors:  M R Munetz; T P Grande; M R Chambers
Journal:  Community Ment Health J       Date:  2001-08

8.  Toward a national consumer survey: evaluation of the CABHS and MHSIP instruments.

Authors:  S V Eisen; J A Shaul; H S Leff; V Stringfellow; B R Clarridge; P D Cleary
Journal:  J Behav Health Serv Res       Date:  2001-08       Impact factor: 1.505

9.  Assessments, interventions, and outcomes: who cares? Introduction.

Authors:  B H McFarland
Journal:  Community Ment Health J       Date:  2001-04

10.  High concordance between self-reported medication and official prescription database information.

Authors:  Jari Haukka; Jaana Suvisaari; Annamari Tuulio-Henriksson; Jouko Lönnqvist
Journal:  Eur J Clin Pharmacol       Date:  2007-08-22       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.